Regulatory Status of Cosmetic and Personal Care Products in the US Cosmetic and personal care products sold in the US are regulated by the FDA under the Federal Food, Drug and Cosmetic (FD&C) Act of 1938. In spite of the fact that cosmetics have an excellent safety record, key statutory
Effective July 14, 2022 CPT management, in conjunction with our corporate attorney, has generated a risk assessment, in reference to Executive Order 242, 243 and 292. Based upon the following factors, we are transitioning to Phase II of our BioSafety and Security Policy, effective July 14, 2022. Activities were assessed
CPT℠ has implemented a Biosafety and Security Policy, with the core objective of establishing sustainable safe operations for our employees, subjects and visitors, in response to the COVID‐19 pandemic. Coronavirus Disease 2019 (COVID‐19) is a respiratory disease caused by the SARS‐CoV‐ 2 virus. CPT℠ based the framework of this policy
CPT℠ management continues to monitor our comprehensive approach assessing our readiness across all critical departmental functions, during the evolving situation surrounding COVID-19 and Executive Orders 107 and 108 (effective Saturday 3/21/20) and Executive Order 119 (effective Tuesday 4/7/20) in New Jersey. CPT℠ remains committed to ensuring our clients get the
CPT℠ management has launched a comprehensive approach to assess our readiness across all critical departmental functions, during the evolving situation surrounding COVID-19 and Executive Order 107 and 108 effective Saturday (3/21/20) in New Jersey. CPT℠ remains committed to ensuring our clients get the personalized service which is our hallmark, combined
Craig Weiss, CPT℠’s President and Co-CEO attended the 2019 in-cosmetics® North American conference in New York on October 23rd, 2019. Heading into its 4th year, in-cosmetics® North America is an interactive exhibition that brings personal ingredient supplies together with finished product manufacturers who are looking to discover new brands and
The Juvenile Diabetes Research Foundation (JDRF): One Walk is an event that is near and dear to our hearts here at CPT℠. We are proud to sponsor Shannon’s Sugar Shakers for a third year. Shannon’s Sugar Shakers is a team created by the incredible Shannon Marren, who was diagnosed with
Family-Owned Consumer Product Testing Company Establishes Permanent Home in Essex County with EDA Resources Product Testing Lab Creates Jobs, Supports Global Companies From left to right, Lon Weiss, COO and Co-CEO, CPTC; Robert Frega, Senior Vice President, Bank of America; Monika Athwal, Business Development Officer, EDA; Melissa Orsen, CEO, EDA;
For Businesses
For Panelists
Regulatory Status of Cosmetic and Personal Care Products in the US Cosmetic and personal care products sold in the US are regulated by the FDA
Effective July 14, 2022 CPT management, in conjunction with our corporate attorney, has generated a risk assessment, in reference to Executive Order 242, 243 and
CPT℠ has implemented a Biosafety and Security Policy, with the core objective of establishing sustainable safe operations for our employees, subjects and visitors, in response
CPT℠ management continues to monitor our comprehensive approach assessing our readiness across all critical departmental functions, during the evolving situation surrounding COVID-19 and Executive Orders
CPT℠ management has launched a comprehensive approach to assess our readiness across all critical departmental functions, during the evolving situation surrounding COVID-19 and Executive Order
Craig Weiss, CPT℠’s President and Co-CEO attended the 2019 in-cosmetics® North American conference in New York on October 23rd, 2019. Heading into its 4th year,
The Juvenile Diabetes Research Foundation (JDRF): One Walk is an event that is near and dear to our hearts here at CPT℠. We are proud
Family-Owned Consumer Product Testing Company Establishes Permanent Home in Essex County with EDA Resources Product Testing Lab Creates Jobs, Supports Global Companies From left to
New Events Coming Soon!
70 New Dutch Ln
Fairfield, NJ 07004
973-808-7111
FDA
Registration# 1000151293
DEA
Registration# RC0199744 (Analytical Lab)
Schedule I-V license
Remember, Schedules I-II require DEA Form 222
Registration# RC0171568 (Researcher)
US EPA/NJ DEP
Registration# NJD982726648